ALLIANCEBERNSTEIN L.P. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$425,246
+71.6%
137,620
+43.3%
0.00%
Q1 2024$247,783
+3.2%
96,0400.0%0.00%
Q4 2023$240,100
+29.8%
96,040
+5.4%
0.00%
Q3 2023$184,933
-4.5%
91,100
+8.2%
0.00%
Q2 2023$193,591
+11.5%
84,170
+46.9%
0.00%
Q1 2023$173,619
+51.8%
57,300
+16.7%
0.00%
Q4 2022$114,403
+87.5%
49,100
+54.4%
0.00%
Q3 2022$61,000
-7.6%
31,800
+31.4%
0.00%
Q2 2022$66,000
+57.1%
24,200
+71.6%
0.00%
Q1 2022$42,000
-23.6%
14,1000.0%0.00%
Q4 2021$55,000
-8.3%
14,1000.0%0.00%
Q3 2021$60,000
+39.5%
14,1000.0%0.00%
Q2 2021$43,000
-84.8%
14,100
-52.7%
0.00%
Q3 2018$282,00029,8210.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Two Seas Capital LP 7,504,193$17,484,77016.61%
Whitefort Capital Management, LP 3,850,769$8,972,2926.97%
FourWorld Capital Management LLC 2,000,090$4,660,2106.41%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 187,400$436,6420.53%
Oasis Management Co Ltd. 1,088,895$2,537,1250.50%
Rubric Capital Management LP 3,466,281$8,076,4350.35%
Tejara Capital Ltd 200,000$466,0000.27%
Hudson Bay Capital Management LP 4,851,416$11,303,7990.12%
ETF MANAGERS GROUP, LLC 639,973$1,491,1370.07%
Kepos Capital LP 200,000$4660.07%
View complete list of ARBUTUS BIOPHARMA CORP shareholders